HU171237B - Sposob poluchenija proizvodnykh 4-/fenoksi-metil/-piperidina - Google Patents

Sposob poluchenija proizvodnykh 4-/fenoksi-metil/-piperidina

Info

Publication number
HU171237B
HU171237B HU76BO00001639A HUBO001639A HU171237B HU 171237 B HU171237 B HU 171237B HU 76BO00001639 A HU76BO00001639 A HU 76BO00001639A HU BO001639 A HUBO001639 A HU BO001639A HU 171237 B HU171237 B HU 171237B
Authority
HU
Hungary
Prior art keywords
piperidine
phenoxy
methyl
preparing derivatives
derivatives
Prior art date
Application number
HU76BO00001639A
Other languages
English (en)
Hungarian (hu)
Inventor
Walter-Gunar Friebe
Max Thiel
Kurt Stach
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of HU171237B publication Critical patent/HU171237B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
HU76BO00001639A 1975-11-07 1976-11-01 Sposob poluchenija proizvodnykh 4-/fenoksi-metil/-piperidina HU171237B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752549999 DE2549999A1 (de) 1975-11-07 1975-11-07 Piperidin-derivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
HU171237B true HU171237B (hu) 1977-12-28

Family

ID=5961166

Family Applications (1)

Application Number Title Priority Date Filing Date
HU76BO00001639A HU171237B (hu) 1975-11-07 1976-11-01 Sposob poluchenija proizvodnykh 4-/fenoksi-metil/-piperidina

Country Status (20)

Country Link
US (1) US4243807A (en:Method)
JP (1) JPS6055509B2 (en:Method)
AT (1) AT352726B (en:Method)
BE (1) BE847973A (en:Method)
CA (1) CA1077942A (en:Method)
CH (3) CH624102A5 (en:Method)
DD (1) DD126942A5 (en:Method)
DE (1) DE2549999A1 (en:Method)
DK (1) DK494876A (en:Method)
FI (1) FI763148A7 (en:Method)
FR (1) FR2330678A1 (en:Method)
GB (1) GB1502050A (en:Method)
HU (1) HU171237B (en:Method)
IE (1) IE43866B1 (en:Method)
IT (1) IT1063618B (en:Method)
LU (1) LU76141A1 (en:Method)
NL (1) NL7612286A (en:Method)
SE (1) SE7612234L (en:Method)
SU (3) SU633473A3 (en:Method)
ZA (1) ZA766381B (en:Method)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA848275B (en) * 1983-12-28 1985-08-28 Degussa New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
US4556664A (en) * 1984-03-13 1985-12-03 Gunnar A. K. Aberg Method and composition for the treatment of cardiac arrhythmias
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
US5231184A (en) * 1987-11-23 1993-07-27 Janssen Pharmaceutica N.V. Pridazinamine derivatives
US4822778A (en) * 1988-01-19 1989-04-18 Gunnar Aberg Membrane stabilizing phenoxy-piperidine compounds and pharmaceutical compositions employing such compounds
US5109002A (en) * 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines
IL99537A (en) * 1990-09-27 1995-11-27 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical compositions containing them
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
US5264420A (en) * 1990-09-27 1993-11-23 Merck & Co., Inc. Fibrinogen receptor antagonists
FR2667317B1 (fr) * 1990-10-02 1992-12-04 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FI934894L (fi) * 1991-05-07 1993-11-05 Merck & Co Inc Fibrinogenreceptorantagonister
US5321034A (en) * 1991-05-07 1994-06-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5389631A (en) * 1991-10-29 1995-02-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5416099A (en) * 1991-10-29 1995-05-16 Merck & Co., Inc. Fibrinogen receptor antagonists
US5272158A (en) * 1991-10-29 1993-12-21 Merck & Co., Inc. Fibrinogen receptor antagonists
US5358956A (en) * 1992-10-14 1994-10-25 Merck & Co., Inc. Fibrinogen receptor antagonists
CA2144763A1 (en) * 1992-10-14 1994-04-28 George D. Hartman Fibrinogen receptor antagonists
CA2150550A1 (en) * 1992-12-01 1994-06-09 Melissa S. Egbertson Fibrinogen receptor antagonists
US5441952A (en) * 1993-04-05 1995-08-15 Merck & Co., Inc. Fibrinogen receptor antagonists
US5334596A (en) * 1993-05-11 1994-08-02 Merck & Co., Inc. Fibrinogen receptor antagonists
US5397791A (en) * 1993-08-09 1995-03-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5821241A (en) * 1994-02-22 1998-10-13 Merck & Co., Inc. Fibrinogen receptor antagonists
US5719144A (en) * 1995-02-22 1998-02-17 Merck & Co., Inc. Fibrinogen receptor antagonists
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
KR100403246B1 (ko) * 1995-09-28 2004-02-11 가켄 세이야쿠 가부시키가이샤 4-메틸렌피페리딘의제조방법
US5789421A (en) * 1995-10-26 1998-08-04 Merck & Co., Inc. Fibrinogen receptor antagonist
US5780480A (en) * 1996-02-28 1998-07-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5889023A (en) * 1996-05-10 1999-03-30 Merck & Co., Inc. Fibrinogen receptor antagonist
US5981584A (en) * 1997-02-06 1999-11-09 Merck & Co., Inc. Fibrinogen receptor antagonist prodrugs
JP5405571B2 (ja) * 2008-07-24 2014-02-05 セラヴァンス, インコーポレーテッド 3−(フェノキシフェニルメチル)ピロリジン化合物
TWI461407B (zh) 2008-11-14 2014-11-21 Theravance Biopharma R & D Ip Llc 製備4-〔2-(2-氟苯氧基甲基)苯基〕哌啶化合物之方法
EP2419405A1 (en) * 2009-04-15 2012-02-22 Theravance, Inc. 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
EP2454234B1 (en) * 2009-07-13 2018-04-11 Theravance Biopharma R&D IP, LLC 3-phenoxymethylpyrrolidine compounds
WO2011011231A1 (en) 2009-07-21 2011-01-27 Theravance, Inc. 3-phenoxymethylpyrrolidine compounds
US8778949B2 (en) * 2010-01-11 2014-07-15 Theravance Biopharma R&D Ip, Llc 1-(2-phenoxymethylphenyl)piperazine compounds
EP2550252B1 (en) * 2010-03-22 2015-05-06 Theravance Biopharma R&D IP, LLC 1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds
CA2811641A1 (en) 2010-10-11 2012-04-19 Theravance, Inc. Serotonin reuptake inhibitors
WO2012075239A1 (en) 2010-12-03 2012-06-07 Theravance, Inc. Serotonin reuptake inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268951A (en) * 1969-06-12 1972-03-29 Pfizer Ltd Phenoxy-amines
DE2245061A1 (de) * 1972-09-14 1974-03-28 Boehringer Mannheim Gmbh Derivate des adenins
DE2401254A1 (de) * 1974-01-11 1975-11-27 Boehringer Mannheim Gmbh Neue derivate von n hoch 6-substituierten adeninen
DE2550000A1 (de) * 1975-11-07 1977-05-12 Boehringer Mannheim Gmbh Neue purin-derivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
NL7612286A (nl) 1977-05-10
SU633473A3 (ru) 1978-11-15
IE43866L (en) 1977-05-07
DD126942A5 (en:Method) 1977-08-24
GB1502050A (en) 1978-02-22
FI763148A7 (en:Method) 1977-05-08
IE43866B1 (en) 1981-06-17
JPS6055509B2 (ja) 1985-12-05
CH627166A5 (en:Method) 1981-12-31
DE2549999A1 (de) 1977-05-12
ATA823776A (de) 1979-03-15
CH625788A5 (en:Method) 1981-10-15
BE847973A (fr) 1977-05-04
CH624102A5 (en:Method) 1981-07-15
DE2549999C2 (en:Method) 1989-01-26
US4243807A (en) 1981-01-06
SU867298A3 (ru) 1981-09-23
SU662009A3 (ru) 1979-05-05
DK494876A (da) 1977-05-08
FR2330678B1 (en:Method) 1980-11-07
AT352726B (de) 1979-10-10
JPS5259163A (en) 1977-05-16
LU76141A1 (en:Method) 1977-05-18
SE7612234L (sv) 1977-05-07
IT1063618B (it) 1985-02-11
ZA766381B (en) 1977-10-26
CA1077942A (en) 1980-05-20
FR2330678A1 (fr) 1977-06-03

Similar Documents

Publication Publication Date Title
HU171237B (hu) Sposob poluchenija proizvodnykh 4-/fenoksi-metil/-piperidina
HU179012B (en) Process for preparing 2-phenyl-3-benzoyl-aenzo-thiophene derivatives
YU39479B (en) Process for the manufacture of thieno-pyridine derivatives
YU237276A (en) Process for obtaining 2-amino-4-pyrimidone derivatives
YU25576A (en) Process for preparing new oxadiazolinone derivatives
HU171395B (hu) Sposob poluchenija proizvodnykh rifamicina
HU175652B (hu) Sposob poluchenija proizvodnykh l-piroglutamil-l-gistidina
CS189782B2 (en) Process for preparing derivatives of diaminoandrostane
HU175412B (hu) Sposob poluchenija proizvodnykh fosforo-dikhlorid-tiolata
CS191319B2 (en) Process for preparing derivatives of 2-nitro-3-phenylbenzofurane
CS191308B2 (en) Process for preparing derivatives of diarylhydroxybutylamines
CS191981B2 (en) Process for preparing derivatives of 5-androsten-17-one
JPS51149251A (en) Process for preparing hydroatropate derivatives
CS189751B2 (en) Process for preparing derivatives of diphenyletheres
GB1484117A (en) Process for the preparation of carbonyl alpha-perfluoro derivatives
JPS51127059A (en) Process for preparing transsdecalin derivatives
YU39478B (en) Process for the manufacture of azomethine derivatives
HU172550B (hu) Sposob poluchenija novykh 3-aciloksimetil-cefemnykh proizvodnykh
PT65120A (en) Process for the preparation of novel diureide derivatives
HU175238B (hu) Sposob poluchenija proizvodnykh tienil-prostaglandina
HU172280B (hu) Sposob poluchenija proizvodnykh tetragidro-tieno-piridina
HU172451B (hu) Sposob poluchenija proizvodnykh beta-nitropirazola
JPS5277088A (en) Process for preparing pyranopyrazole 33carboxylate derivative
GB1477990A (en) Process for the preparation of thieno-pyridine derivatives
CH613691A5 (en) Process for the preparation of novel 1-indolinylguanidine derivatives

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee